Stephen G. Carter

Nessuna posizione attualmente

70 anni

Health Technology

Consumer Non-Durables

Profilo

Stephen G.
Carter worked as the Director, Chief Scientific Officer & VP at Vaso Active Pharmaceuticals, Inc. from 2009 to 2012.
He also worked as the Chief Scientific Officer at Biochemics, Inc.

Precedenti posizioni note di Stephen G. Carter

Società	Posizione	Fine
Vaso Active Pharmaceuticals, Inc. Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish.	Direttore Tecnico/Scientifico/R&S	06/11/2012
Biochemics, Inc. Biochemics, Inc. Household/Personal CareConsumer Non-Durables Biochemics, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Danvers, MA.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Stephen G. Carter

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Stephen G. Carter

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Vaso Active Pharmaceuticals, Inc. Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish.	Health Technology
Biochemics, Inc. Biochemics, Inc. Household/Personal CareConsumer Non-Durables Biochemics, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Danvers, MA.	Consumer Non-Durables